Taken together, tumor-derived galectin-9 induces apoptosis in tumor-infiltrating CD8+ T cells and blockade of TIM-3 attenuates the apoptosis and augments anti-tumor activity of infiltrating CD8+ T cells. The gene discussed is HAVCR2; the disease is neoplasm.